Marc Deffains1,2, Liliya Iskhakova1,2, Shiran Katabi1, Zvi Israel3, Hagai Bergman1,2,3. 1. Department of Medical Neurobiology, Institute of Medical Research Israel-Canada (IMRIC), The Hebrew University-Hadassah Medical School, Jerusalem, Israel. 2. The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University, Jerusalem, Israel. 3. Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel.
Abstract
BACKGROUND: The efficacy of deep brain stimulation (DBS) - primarily of the subthalamic nucleus (STN) - for advanced Parkinson's disease (PD) is commonly attributed to the suppression of pathological synchronous β oscillations along the cortico-thalamo-basal ganglia network. Conventional continuous high-frequency DBS indiscriminately influences pathological and normal neural activity. The DBS protocol would therefore be more effective if stimulation was only applied when necessary (closed-loop adaptive DBS). OBJECTIVES AND METHODS: Our study aimed to identify a reliable biomarker of the pathological neuronal activity in parkinsonism that could be used as a trigger for adaptive DBS. To this end, we examined the oscillatory features of paired spiking activities recorded in three distinct nodes of the basal ganglia network of 2 African green monkeys before and after induction of parkinsonism (by MPTP intoxication). RESULTS: Parkinsonism-related basal ganglia β oscillations consisted of synchronized time-limited episodes, rather than a continuous stretch, of β oscillatory activity. Episodic basal ganglia β oscillatory activity, although prolonged in parkinsonism, was not necessarily pathological given that short β episodes could also be detected in the healthy state. Importantly, prolongation of the basal ganglia β episodes was more pronounced than their intensification in the parkinsonian state-especially in the STN. Hence, deletion of longer β episodes was more effective than deletion of stronger β episodes in reducing parkinsonian STN synchronized oscillatory activity. CONCLUSIONS: Prolonged STN β episodes are pathological in parkinsonism and can be used as optimal trigger for future adaptive DBS applications.
BACKGROUND: The efficacy of deep brain stimulation (DBS) - primarily of the subthalamic nucleus (STN) - for advanced Parkinson's disease (PD) is commonly attributed to the suppression of pathological synchronous β oscillations along the cortico-thalamo-basal ganglia network. Conventional continuous high-frequency DBS indiscriminately influences pathological and normal neural activity. The DBS protocol would therefore be more effective if stimulation was only applied when necessary (closed-loop adaptive DBS). OBJECTIVES AND METHODS: Our study aimed to identify a reliable biomarker of the pathological neuronal activity in parkinsonism that could be used as a trigger for adaptive DBS. To this end, we examined the oscillatory features of paired spiking activities recorded in three distinct nodes of the basal ganglia network of 2 African green monkeys before and after induction of parkinsonism (by MPTP intoxication). RESULTS:Parkinsonism-related basal ganglia β oscillations consisted of synchronized time-limited episodes, rather than a continuous stretch, of β oscillatory activity. Episodic basal ganglia β oscillatory activity, although prolonged in parkinsonism, was not necessarily pathological given that short β episodes could also be detected in the healthy state. Importantly, prolongation of the basal ganglia β episodes was more pronounced than their intensification in the parkinsonian state-especially in the STN. Hence, deletion of longer β episodes was more effective than deletion of stronger β episodes in reducing parkinsonian STN synchronized oscillatory activity. CONCLUSIONS: Prolonged STN β episodes are pathological in parkinsonism and can be used as optimal trigger for future adaptive DBS applications.
Authors: Ying Yu; David Escobar Sanabria; Jing Wang; Claudia M Hendrix; Jianyu Zhang; Shane D Nebeck; Alexia M Amundson; Zachary B Busby; Devyn L Bauer; Matthew D Johnson; Luke A Johnson; Jerrold L Vitek Journal: J Neurosci Date: 2021-01-22 Impact factor: 6.167
Authors: Chien-Hung Yeh; Bassam Al-Fatly; Andrea A Kühn; Anders C Meidahl; Gerd Tinkhauser; Huiling Tan; Peter Brown Journal: Clin Neurophysiol Date: 2020-06-29 Impact factor: 3.708
Authors: Robert S Eisinger; Jackson N Cagle; Enrico Opri; Jose Alcantara; Stephanie Cernera; Kelly D Foote; Michael S Okun; Aysegul Gunduz Journal: J Neurosci Date: 2020-02-27 Impact factor: 6.167
Authors: R W Anderson; Y M Kehnemouyi; R S Neuville; K B Wilkins; C M Anidi; M N Petrucci; J E Parker; A Velisar; H M Brontë-Stewart Journal: J Neurosci Methods Date: 2020-06-18 Impact factor: 2.390
Authors: Andrea A Kühn; R Mark Richardson; Wolf-Julian Neumann; Robert S Turner; Benjamin Blankertz; Tom Mitchell Journal: Neurotherapeutics Date: 2019-01 Impact factor: 7.620
Authors: Joachim K Krauss; Nir Lipsman; Tipu Aziz; Alexandre Boutet; Peter Brown; Jin Woo Chang; Benjamin Davidson; Warren M Grill; Marwan I Hariz; Andreas Horn; Michael Schulder; Antonios Mammis; Peter A Tass; Jens Volkmann; Andres M Lozano Journal: Nat Rev Neurol Date: 2020-11-26 Impact factor: 42.937